Rep. Doggett’s Reaction to Trump’s Executive Order on Drug Prices

Contact: Alexis.Torres@mail.house.gov

Washington, D.C.—Today, U.S. Representative Lloyd Doggett (D-Texas), Ranking Member of the House Ways and Means Health Subcommittee, released the following statement:

“Rather than changing the law, Trump issues another press release that will offer consumers little or nothing. Begging Big Pharma to show some benevolence to the taxpayers and consumers, whom they continue to price gouge, will do nothing to assure access to affordable medications. As in his first term, Trump keeps talking big about drug prices but fails to accomplish anything. Simply by utilizing his existing authority to lower prices for drugs made possible through taxpayer research investments, as I have repeatedly urged, he could provide genuine relief to millions of Americans. And since Trump has failed to include real drug price relief this week in his ‘one big, beautiful bill,’ he could at least insist that House Republicans stop their continued attempt to weaken or repeal Medicare price negotiations.”